• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IBX
Click for more information
4.35% 4.8¢

IMAGION BIOSYSTEMS LIMITED - Announcements

Market Cap $819.8K  ! watchlist Created with Sketch. Add to my watchlist

Imagion Biosystems Limited is a medical imaging company engaged in developing medical... Imagion Biosystems Limited is a medical imaging company engaged in developing medical imaging technologies for various cancer types. The Company uses bio-safe magnetic nanoparticles to detect cancer and other diseases. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The Company operates through Research and Development segment. It is advancing clinical development of its MagSense platform technology to revolutionize cancer diagnosis, introducing molecular imaging to Magnetic resonance imaging (MRI). The Company’s lead program has demonstrated its technology embodied in MagSense HER2 Imaging Agent (MSH2IA) is safe and well-tolerated in patients diagnosed with HER2+ breast cancer. Its MagSense pipeline includes prostate cancer, ovarian cancer, pancreatic cancer, and brain cancer programs. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.More

Corporate Spotlight

We are a multidisciplinary team with expertise in the physics of magnetic fields and nanotechnology & the medical application of these fields. Our focus is in the rapidly emerging field of nanobiotechnology with an emphasis on the early detection and localization of cancer and other human diseases.
View the full Corporate Spotlight arrow Created with Sketch.

Imagion Biosystems pioneering medical imaging

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IBX Notification regarding unquoted securities - IBX19/09/24
IBX IBX receives US patent related to treatment of diseasePRICE SENSITIVE12/03/19
IBX FY2018 Appendix 4E and Preliminary ReportPRICE SENSITIVE28/02/19
IBX Imagion Biosystems initiates toxicology study20/02/19
IBX Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
IBX Becoming a substantial holder30/01/19
IBX Becoming a substantial holder30/01/19
IBX IBX teams with Planet Innovation to develop MagSense17/12/18
IBX Cleansing Notice28/11/18
IBX Appendix 3B28/11/18
IBX Imagion Biosystems Raises $4.3M Via Rights IssuePRICE SENSITIVE19/11/18
IBX Change of Director's Interest Notice30/10/18
IBX Appendix 4C - quarterlyPRICE SENSITIVE30/10/18
IBX Appendix 3B - Completion of Rights Issue24/10/18
IBX Completion of Rights Issue19/10/18
IBX Despatch of Rights Issue Offer DocumentsPRICE SENSITIVE03/10/18
IBX Letter to shareholders - Rights Issue25/09/18
IBX Letter to Option Holders - Rights Issue24/09/18
IBX Cleansing Notice - Rights Issue24/09/18
IBX Appendix 3B - Rights Issue24/09/18
IBX Rights Issue Offer DocumentPRICE SENSITIVE24/09/18
IBX Market Announcement - Reinstatement to official quotationPRICE SENSITIVE20/09/18
IBX Pro-Rata Non-Renounceable Rights IssuePRICE SENSITIVE20/09/18
IBX Voluntary SuspensionPRICE SENSITIVE17/09/18
IBX Trading HaltPRICE SENSITIVE13/09/18
IBX Imagion Biosystems Hits Nanoparticle Formulation MilestonePRICE SENSITIVE10/09/18
IBX Half Yearly Report and AccountsPRICE SENSITIVE23/08/18
IBX Response to Appendix 4C QueryPRICE SENSITIVE17/08/18
IBX Appointment of Director and Appendix 3X30/07/18
IBX Appendix 4C - quarterlyPRICE SENSITIVE27/07/18 download Created with Sketch. 210.55KB
IBX Change in substantial holding19/06/18 download Created with Sketch. 229.9KB
IBX Appendix 3B19/06/18 download Created with Sketch. 579.38KB
IBX Appendix 3Y x 514/06/18 download Created with Sketch. 868.32KB
IBX Cleansing Notice06/06/18 download Created with Sketch. 94.97KB
IBX Appendix 3B06/06/18 download Created with Sketch. 443.92KB
IBX Release of shares from escrow31/05/18 download Created with Sketch. 107.04KB
IBX Results of Annual General Meeting31/05/18 download Created with Sketch. 309.26KB
IBX Investor Presentation31/05/18 download Created with Sketch. 2.16MB
IBX Chairman's Address to Shareholders at Annual General Meeting31/05/18 download Created with Sketch. 47.28KB
IBX Amendment to Notice of Annual General Meeting23/05/18 download Created with Sketch. 128.22KB
IBX MD Anderson Cancer Center Takes Equity Stake in IBXPRICE SENSITIVE23/05/18 download Created with Sketch. 88.04KB
IBX Final Director's Interest Notice04/05/18
IBX Initial Director's Interest Notice04/05/18
IBX Notice of Annual General Meeting/Proxy Form02/05/18
IBX Appendix 4C - quarterlyPRICE SENSITIVE27/04/18
IBX Director Appointment/Resignation26/04/18
IBX Appendix 4G and Corporate Governance Statement24/04/18
IBX Annual Report to shareholders24/04/18
IBX Imagion Biosystems Reports Progress on Regulatory Pathway04/04/18
IBX IBX Announces Relocation of U.S. Operations to San DiegoPRICE SENSITIVE03/04/18
IBX FY2017 Appendix 4E and Financial ReportPRICE SENSITIVE28/02/18
IBX IBX appoints Vice President of Clinical Research22/02/18
IBX Notice of change of interests of substantial holder - IBX12/02/18
IBX Appendix 3B - Quotation of shares released from escrow12/02/18
IBX Quarterly Update and Appendix 4CPRICE SENSITIVE31/01/18
IBX Release of shares from escrow23/01/18
IBX Investor Update12/12/17
IBX Investor Conference Call06/12/17
IBX Change of Director's Interest Notice24/11/17
IBX Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
IBX Investor Update25/10/17
IBX Imagion Biosystems Secures Nanoparticle ManufacturerPRICE SENSITIVE10/10/17
IBX Appendix 4D and Half-Year ReportPRICE SENSITIVE31/08/17
IBX Imagion Biosystems Initiates MagSense Instrument DevelopmentPRICE SENSITIVE15/08/17
IBX Appendix 4C & Restated Statements for year ended 31 Dec 2016PRICE SENSITIVE31/07/17
IBX Becoming a substantial holder/IBX20/07/17
IBX Imagion Biosystems identifies key operational objectivesPRICE SENSITIVE12/07/17
IBX Podcast Interview with Health Professional Radio10/07/17
IBX Initial Director's Interest Notice (x6)28/06/17
IBX Investor Presentation22/06/17
IBX Imagion Biosystems lists on ASX22/06/17
IBX Long Term Incentive Plan21/06/17
IBX Securities Trading Policy21/06/17
IBX Senior Scientifc, LLC audited accounts 2014 & 201521/06/17
IBX Senior Scientific, LLC audited accounts 1 Jan to 17 Nov '1621/06/17
IBX Audited accounts to 31 December 201621/06/17
IBX Constitution21/06/17
IBX Replacement Prospectus21/06/17
IBX Appendix 1A and Information Form & Checklist21/06/17
IBX Pre-quotation info- includes Top 20 & Distribution Schedule21/06/17
IBX ASX Notice21/06/17
IBX Admission to Official ListPRICE SENSITIVE21/06/17
IBX Notification regarding unquoted securities - IBX
19/09/24
IBX IBX receives US patent related to treatment of disease
12/03/19PRICE SENSITIVE
IBX FY2018 Appendix 4E and Preliminary Report
28/02/19PRICE SENSITIVE
IBX Imagion Biosystems initiates toxicology study
20/02/19
IBX Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
IBX Becoming a substantial holder
30/01/19
IBX Becoming a substantial holder
30/01/19
IBX IBX teams with Planet Innovation to develop MagSense
17/12/18
IBX Cleansing Notice
28/11/18
IBX Appendix 3B
28/11/18
IBX Imagion Biosystems Raises $4.3M Via Rights Issue
19/11/18PRICE SENSITIVE
IBX Change of Director's Interest Notice
30/10/18
IBX Appendix 4C - quarterly
30/10/18PRICE SENSITIVE
IBX Appendix 3B - Completion of Rights Issue
24/10/18
IBX Completion of Rights Issue
19/10/18
IBX Despatch of Rights Issue Offer Documents
03/10/18PRICE SENSITIVE
IBX Letter to shareholders - Rights Issue
25/09/18
IBX Letter to Option Holders - Rights Issue
24/09/18
IBX Cleansing Notice - Rights Issue
24/09/18
IBX Appendix 3B - Rights Issue
24/09/18
IBX Rights Issue Offer Document
24/09/18PRICE SENSITIVE
IBX Market Announcement - Reinstatement to official quotation
20/09/18PRICE SENSITIVE
IBX Pro-Rata Non-Renounceable Rights Issue
20/09/18PRICE SENSITIVE
IBX Voluntary Suspension
17/09/18PRICE SENSITIVE
IBX Trading Halt
13/09/18PRICE SENSITIVE
IBX Imagion Biosystems Hits Nanoparticle Formulation Milestone
10/09/18PRICE SENSITIVE
IBX Half Yearly Report and Accounts
23/08/18PRICE SENSITIVE
IBX Response to Appendix 4C Query
17/08/18PRICE SENSITIVE
IBX Appointment of Director and Appendix 3X
30/07/18
IBX Appendix 4C - quarterly
27/07/18PRICE SENSITIVE download Created with Sketch. 210.55KB
IBX Change in substantial holding
19/06/18 download Created with Sketch. 229.9KB
IBX Appendix 3B
19/06/18 download Created with Sketch. 579.38KB
IBX Appendix 3Y x 5
14/06/18 download Created with Sketch. 868.32KB
IBX Cleansing Notice
06/06/18 download Created with Sketch. 94.97KB
IBX Appendix 3B
06/06/18 download Created with Sketch. 443.92KB
IBX Release of shares from escrow
31/05/18 download Created with Sketch. 107.04KB
IBX Results of Annual General Meeting
31/05/18 download Created with Sketch. 309.26KB
IBX Investor Presentation
31/05/18 download Created with Sketch. 2.16MB
IBX Chairman's Address to Shareholders at Annual General Meeting
31/05/18 download Created with Sketch. 47.28KB
IBX Amendment to Notice of Annual General Meeting
23/05/18 download Created with Sketch. 128.22KB
IBX MD Anderson Cancer Center Takes Equity Stake in IBX
23/05/18PRICE SENSITIVE download Created with Sketch. 88.04KB
IBX Final Director's Interest Notice
04/05/18
IBX Initial Director's Interest Notice
04/05/18
IBX Notice of Annual General Meeting/Proxy Form
02/05/18
IBX Appendix 4C - quarterly
27/04/18PRICE SENSITIVE
IBX Director Appointment/Resignation
26/04/18
IBX Appendix 4G and Corporate Governance Statement
24/04/18
IBX Annual Report to shareholders
24/04/18
IBX Imagion Biosystems Reports Progress on Regulatory Pathway
04/04/18
IBX IBX Announces Relocation of U.S. Operations to San Diego
03/04/18PRICE SENSITIVE
IBX FY2017 Appendix 4E and Financial Report
28/02/18PRICE SENSITIVE
IBX IBX appoints Vice President of Clinical Research
22/02/18
IBX Notice of change of interests of substantial holder - IBX
12/02/18
IBX Appendix 3B - Quotation of shares released from escrow
12/02/18
IBX Quarterly Update and Appendix 4C
31/01/18PRICE SENSITIVE
IBX Release of shares from escrow
23/01/18
IBX Investor Update
12/12/17
IBX Investor Conference Call
06/12/17
IBX Change of Director's Interest Notice
24/11/17
IBX Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
IBX Investor Update
25/10/17
IBX Imagion Biosystems Secures Nanoparticle Manufacturer
10/10/17PRICE SENSITIVE
IBX Appendix 4D and Half-Year Report
31/08/17PRICE SENSITIVE
IBX Imagion Biosystems Initiates MagSense Instrument Development
15/08/17PRICE SENSITIVE
IBX Appendix 4C & Restated Statements for year ended 31 Dec 2016
31/07/17PRICE SENSITIVE
IBX Becoming a substantial holder/IBX
20/07/17
IBX Imagion Biosystems identifies key operational objectives
12/07/17PRICE SENSITIVE
IBX Podcast Interview with Health Professional Radio
10/07/17
IBX Initial Director's Interest Notice (x6)
28/06/17
IBX Investor Presentation
22/06/17
IBX Imagion Biosystems lists on ASX
22/06/17
IBX Long Term Incentive Plan
21/06/17
IBX Securities Trading Policy
21/06/17
IBX Senior Scientifc, LLC audited accounts 2014 & 2015
21/06/17
IBX Senior Scientific, LLC audited accounts 1 Jan to 17 Nov '16
21/06/17
IBX Audited accounts to 31 December 2016
21/06/17
IBX Constitution
21/06/17
IBX Replacement Prospectus
21/06/17
IBX Appendix 1A and Information Form & Checklist
21/06/17
IBX Pre-quotation info- includes Top 20 & Distribution Schedule
21/06/17
IBX ASX Notice
21/06/17
IBX Admission to Official List
21/06/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
4.8¢ 		Change
0.002(4.35%) 		Mkt cap ! $819.8K
Open High Low Value Volume
4.5¢ 4.8¢ 4.5¢ $7.822K 164.4K

Buyers (Bids)

No. Vol. Price($)
2 69259 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 31838 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
4.8¢ 		  Change
0.002 ( 4.35 %)
Open High Low Volume
4.7¢ 4.8¢ 4.7¢ 41444
Last updated 13.59pm 15/11/2024 ?
IBX (ASX) Chart

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.